BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1801747)

  • 1. Probing the distance between the two binding sites of hirudin for its interaction with the active site and the fibrin(ogen)-binding site of alpha-thrombin.
    Wagner U; Schmitz T; Otte M; Dodt J
    Biomed Biochim Acta; 1991; 50(4-6):707-10. PubMed ID: 1801747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of site specific amino acid exchanges in hirudin on the thrombin-hirudin interaction.
    Köhler S; Dodt J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):24-9. PubMed ID: 2459027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
    Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
    Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of site specific hirudin variants with alpha-thrombin.
    Dodt J; Köhler S; Baici A
    FEBS Lett; 1988 Feb; 229(1):87-90. PubMed ID: 3345842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin.
    Yue SY; Konishi Y
    Drug Des Discov; 1994 Jul; 12(1):1-17. PubMed ID: 7578804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen.
    Hogg PJ; Jackson CM; Labanowski JK; Bock PE
    J Biol Chem; 1996 Oct; 271(42):26088-95. PubMed ID: 8824251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant hirudin: genetic engineering and structure analysis.
    Märki WE; Grossenbacher H; Grütter MG; Liersch MH; Meyhack B; Heim J
    Semin Thromb Hemost; 1991 Apr; 17(2):88-93. PubMed ID: 1771417
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of hirudin with the dysthrombins Quick I and II.
    Stone SR; Schmitz T; Henriksen RA; Hofsteenge J; Dodt J
    Biochemistry; 1991 Jul; 30(26):6392-7. PubMed ID: 2054344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin.
    Krstenansky JL; Broersma RJ; Owen TJ; Payne MH; Yates MT; Mao SJ
    Thromb Haemost; 1990 Apr; 63(2):208-14. PubMed ID: 2363122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin interactions with hirudin.
    Fenton JW
    Semin Thromb Hemost; 1989 Jul; 15(3):265-8. PubMed ID: 2688098
    [No Abstract]   [Full Text] [Related]  

  • 17. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
    Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
    J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
    Chang JY
    Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1991 Nov; 66(5):592-7. PubMed ID: 1839474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL; Mao SJ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.